References
AMINIAN, K., MASHAYEKHI, F., MIRZANEJAD, L. & SALEHI, Z. 2019. A functional genetic variant in GAS5 lncRNA (rs145204276) modulates p27(Kip1) expression and confers risk for gastric cancer. J Cell Physiol, 76, 83-85.
BARTONICEK, N., MAAG, J. L. & DINGER, M. E. 2016. Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Molecular cancer, 15, 43.
BHAN, A. & MANDAL, S. S. 2014. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem, 9, 1932-1956.
BROSNAN, C. A. & VOINNET, O. 2009. The long and the short of noncoding RNAs. Current opinion in cell biology, 21, 416-425.
CAO, S., LIU, W., LI, F., ZHAO, W. & QIN, C. 2014. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. International journal of clinical and experimental pathology, 7, 6776.
CHEETHAM, S., GRUHL, F., MATTICK, J. & DINGER, M. 2013. Long noncoding RNAs and the genetics of cancer.British journal of cancer, 108, 2419.
CHEN, G., WANG, Z., WANG, D., QIU, C., LIU, M., CHEN, X., ZHANG, Q., YAN, G. & CUI, Q. 2012. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic acids research, 41, D983-D986.
FOROUZANFAR, M. H., AFSHIN, A., ALEXANDER, L. T., ANDERSON, H. R., BHUTTA, Z. A., BIRYUKOV, S., BRAUER, M., BURNETT, R., CERCY, K. & CHARLSON, F. J. 2016. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388, 1659-1724.
GOTO, Y., KOJIMA, S., NISHIKAWA, R., ENOKIDA, H., CHIYOMARU, T., KINOSHITA, T., NAKAGAWA, M., NAYA, Y., ICHIKAWA, T. & SEKI, N. 2014. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.Oncotarget, 5, 7748.
GU, J., WANG, Y., WANG, X., ZHOU, D., SHAO, C., ZHOU, M. & HE, Z. 2018. Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer.Cancer letters, 434, 1-10.
GUO, Z., WANG, Y., ZHAO, Y., JIN, Y., AN, L., WU, B., LIU, Z., CHEN, X., ZHOU, H. & WANG, H. 2017. Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients. Oncotarget, 8, 62286.
GUPTA, R. A., SHAH, N., WANG, K. C., KIM, J., HORLINGS, H. M., WONG, D. J., TSAI, M.-C., HUNG, T., ARGANI, P. & RINN, J. L. 2010. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071.
HOSEINI, B. L., SAEIDI, M., VAKILI, R., KIANI, M., RABIEI, M., KHAKSHOUR, A. & RASTI SANI, S. J. I. J. O. P. 2014. Assessment the Relationship between Parents’ Literacy Level with Children Growth in Mashhad: An Analytic Descriptive Study. 2, 59-59.
HOSSEINI, M., SAHEBI, R., AGHASIZADEH, M., YAZDI, D. F., SALARIBAGHOONABAD, R., GODSI, A., SOFLAEI, S. S., MOUSAVITAHERABAD, S. P., AHMADIHOSEINI, A. & BAJGIRAN, M. M. J. G. R. 2022. Investigating the predictive value of microRNA21 as a biomarker in induced myocardial infarction animal model. 27,101578.
HU, G., YANG, T., ZHENG, J., DAI, J., NAN, A., LAI, Y., ZHANG, Y., YANG, C. & JIANG, Y. 2015. Functional role and mechanism of lncRNA LOC728228 in malignant 16HBE cells transformed by anti‐benzopyrene‐trans‐7, 8‐dihydrodiol‐9, 10‐epoxide.Molecular carcinogenesis, 54.
KONG, H., WU, Y., ZHU, M., ZHAI, C., QIAN, J., GAO, X., WANG, S., HOU, Y., LU, S. & ZHU, H. 2016. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer. Oncotarget,7, 50428.
KONG, X.-P., YAO, J., LUO, W., FENG, F.-K., MA, J.-T., REN, Y.-P., WANG, D.-L. & BU, R.-F. 2014. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma. Molecular and cellular biochemistry, 394, 177-186.
LI, Q., MA, G., GUO, H., SUN, S., XU, Y. & WANG, B. 2018a. The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer. Journal of gastrointestinal and liver diseases: JGLD, 27, 19-24.
LI, Q., MA, G., GUO, H., SUN, S., XU, Y. & WANG, B. 2018b. The variant rs145204276 of GAS5 is associated with the development and prognosis of gastric cancer. Journal of Gastrointestinal and Liver Diseases, 27, 19-24.
LI, Q., MA, G., SUN, S., XU, Y. & WANG, B. 2018c. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer. Clinics and research in hepatology and gastroenterology .
LI, W., HUANG, K., WEN, F., CUI, G., GUO, H. & ZHAO, S. 2017. Genetic variation of lncRNA GAS5 contributes to the development of lung cancer. Oncotarget, 8, 91025.
LING, H., VINCENT, K., PICHLER, M., FODDE, R., BERINDAN-NEAGOE, I., SLACK, F. J. & CALIN, G. A. 2015. Junk DNA and the long non-coding RNA twist in cancer genetics.Oncogene, 34, 5003.
MARTORELL-MARUGAN, J., TORO-DOMINGUEZ, D., ALARCON-RIQUELME, M. E. & CARMONA-SAEZ, P. 2017. MetaGenyo: a web tool for meta-analysis of genetic association studies.BMC bioinformatics, 18, 563.
MCGUIRE, S. 2016. World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press, 2015. Advances in Nutrition: An International Review Journal, 7, 418-419.
MOURTADA-MAARABOUNI, M., PICKARD, M., HEDGE, V., FARZANEH, F. & WILLIAMS, G. 2009. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer.Oncogene, 28, 195.
OGINO, S., SHIMA, K., NOSHO, K., IRAHARA, N., BABA, Y., WOLPIN, B. M., GIOVANNUCCI, E. L., MEYERHARDT, J. A. & FUCHS, C. S. 2009. A cohort study of p27 localization in colon cancer, body mass index, and patient survival. Cancer Epidemiology and Prevention Biomarkers, 18, 1849-1858.
OLDONI, F., PALMEN, J., GIAMBARTOLOMEI, C., HOWARD, P., DRENOS, F., PLAGNOL, V., HUMPHRIES, S. E., TALMUD, P. J. & SMITH, A. J. J. A. 2016. Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3. 246, 193-201.
PAN, W., LIU, L., WEI, J., GE, Y., ZHANG, J., CHEN, H., ZHOU, L., YUAN, Q., ZHOU, C. & YANG, M. 2016. A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility. Molecular carcinogenesis, 55, 90-96.
RASHIDMAYVAN, M., KHORASANCHI, Z., NATTAGH‐ESHTIVANI, E., ESFEHANI, A. J., SAHEBI, R., SHARIFAN, P., ASSADIAN, P., AGHASIZADEH, M., AVAN, A., GHAYOUR‐MOBARHAN, M. J. M. N. & RESEARCH, F. 2022. Association between inflammatory factors, vitamin D, long non‐coding RNAs, MALAT1 and Adiponectin antisense in individuals with metabolic syndrome. 2200144.
SCHMIDT, L. H., SPIEKER, T., KOSCHMIEDER, S., HUMBERG, J., JUNGEN, D., BULK, E., HASCHER, A., WITTMER, D., MARRA, A. & HILLEJAN, L. 2011. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. Journal of thoracic oncology,6, 1984-1992.
SIEGEL, R. L., MILLER, K. D. & JEMAL, A. 2015. Cancer statistics, 2015. CA: a cancer journal for clinicians, 65, 5-29.
SMITH, C. M. & STEITZ, J. A. 1998. Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Molecular and cellular biology, 18, 6897-6909.
SUN, M., JIN, F.-Y., XIA, R., KONG, R., LI, J.-H., XU, T.-P., LIU, Y.-W., ZHANG, E.-B., LIU, X.-H. & DE, W. 2014. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC cancer, 14, 319.
TANG, Y., WANG, Y., WANG, X., LIU, Y. & ZHENG, K. 2019. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer. Biosci Rep, 19, e415-e421.
TAO, R., HU, S., WANG, S., ZHOU, X., ZHANG, Q., WANG, C., ZHAO, X., ZHOU, W., ZHANG, S., LI, C., ZHAO, H., HE, Y., ZHU, S., XU, J., JIANG, Y., LI, L. & GAO, Y. 2015. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Carcinogenesis, 36,1136-43.
TU, Z.-Q., LI, R.-J., MEI, J.-Z. & LI, X.-H. 2014. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma.International journal of clinical and experimental pathology,7, 4303.
XU, L., XIA, C., XUE, B., SHENG, F., XIONG, J. & WANG, S. 2018. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma.Journal of Bone Oncology, 12, 23-26.
YAN, H., ZHANG, D.-Y., LI, X., YUAN, X.-Q., YANG, Y.-L., ZHU, K.-W., ZENG, H., LI, X.-L., CAO, S. & ZHOU, H.-H. 2017. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution. Leukemia & lymphoma, 58,1948-1957.
YANG, F., BI, J., XUE, X., ZHENG, L., ZHI, K., HUA, J. & FANG, G. 2012. Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells. The FEBS journal, 279, 3159-3165.
YUAN, J., ZHANG, N., ZHENG, Y., CHEN, Y.-D., LIU, J. & YANG, M. 2018. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A. DNA and cell biology, 37,750-757.
ZHANG, F., ZHANG, L. & ZHANG, C. 2016. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies. Tumor Biology,37, 163-175.
ZHENG, Y., SONG, D., XIAO, K., YANG, C., DING, Y., DENG, W. & TONG, S. 2016. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer. Oncotarget,7, 83727.
ZHU, Z., FENG, L., LI, F., XUE, Y., LI, C. & WANG, H. 2017. A novel functional indel polymorphism within long non-coding RNAs growth arrest specific 5 conferred risk for cervical squamous cell carcinoma in Chinese Han populations.Translational Cancer Research, 6, 424-431.
ZHU, Z., XUE, Y., FU, W., LI, C., FENG, L., XING, Y. & WANG, H. 2016. Functional indel polymorphism within lncRNA GAS5 and colorectal carcinoma risk. International Journal of Clinical and Experimental Pathology, 9,11767-11773.
ZHUANG, Y., YIN, H.-T., YIN, X.-L., WANG, J. & ZHANG, D.-P. 2011. High p27 expression is associated with a better prognosis in East Asian non-small cell lung cancer patients.Clinica chimica acta, 412, 2228-2231.
Table 1: Characteristics of the eligible studies included in the meta-analysis.